- AMGN -1.17%
Amgen Inc. (AMGN): Why Do Hedge Funds Recommend This Biotech Stock?
Yahoo Finance · 18 hours ago
Open | 324.70 |
High | 326.97 |
Low | 319.03 |
Mkt Cap | 172.25B |
P/E (TTM) | 55.27 |
Div & Yield | 9.00 & 2.81% |
Prev. Close | 324.36 |
52 Wk. Low | 249.70 |
52 Wk. High | 346.85 |
Related stocks
American multinational biopharmaceutical company
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total. Wikipedia
(USD) | Q2 2024 | Y/Y |
---|---|---|
Revenue | 8.39B | 20.10% ▲ |
Net Income | 746M | 45.90% ▼ |
Diluted EPS | 4.97 | 46.30% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q3 2024 | $5.14 | - |
Q2 2024 | $5.01 | $4.97 |
Q1 2024 | $3.87 | $3.96 |
S&P FuturesES=F | 5,408.50-11.00 (-0.20%) |
Dow FuturesYM=F | 40,368.00-39.00 (-0.10%) |
Nasdaq FuturesNQ=F | 18,388.75-69.50 (-0.38%) |
18,388.75-0.38% | |
5,408.50-0.20% | |
40,368.00-0.10% |